| PUBCHEM ID |
25183667
|
| UNII |
5EH35FF002
|
| Preferred Term |
AMBRISENTAN ACYL .BETA.-D-GLUCURONIDE
|
| CAS |
1106685-58-8
|
| INCHIKEY |
QBHJFBFSJYTXDX-MVTLKLODSA-N
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
Cc1nc(O[C@H](C(c2ccccc2)(c2ccccc2)OC)C(O[C@H]([C@H]([C@@H]([C@H]2O)O)O)O[C@H]2C(O)=O)=O)nc(C)c1
|
| Total Surface Area |
399,89
|
| Relative PSA |
0,35115
|
| TPSA |
177,76
|
| cLogS |
-3,476
|
| MW |
554,55
|
| cLogP |
0,6463
|
| H-Acceptors |
12
|
| H-Donors |
4
|
| Ro5 violations |
2
|
| Druglikeness |
-0,20546
|
| DrugScore |
0,439779490188526
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
none
|
| Blood-Brain Barrier |
BBB+
|
| Human Intestinal Absorption |
HIA-
|
| Caco-2 Permeability I |
Caco2-
|
| Caco-2 Permeability II |
0,5241
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor I |
Non-inhibitor
|
| P-glycoprotein Inhibitor II |
Non-inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Mitochondria
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Non-substrate
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Non-inhibitor
|
| AMES Toxicity |
Non AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
Low FHMT
|
| Fish Toxicity II |
1,4923
|
| Tetrahymena Pyriformis Toxicity I |
High TPT
|
| Tetrahymena Pyriformis Toxicity II |
0,7663
|
| Tetrahymena Pyriformis Toxicity |
Low HBT
|
| Biodegradation |
Not ready biodegradable
|
| Acute Oral Toxicity |
III
|
| Rat Acute Toxicity |
2,5124
|
| Carcinogenicity (Three-class) |
Non-required
|